For more than 20 years, the Division of Health Policy and Insurance Research, HPI, has published studies on pharmaceutical utilization and its determinants in large U.S. populations; impacts of U.S. and state health care and pharmaceutical policies on health care utilization, costs, and outcomes; methods for improving prescribing and clinical decision-making; and the effects of changes in health insurance coverage on the quality and outcomes of health care.
In most low and middle-income countries, most medicines are paid for out of pocket. Often large amounts of scarce resources are wasted, in part because medicines are used inappropriately. To help improve medicine situations for low and middle-income country populations across the world, the group leads and collaborates on major global medicines research activities.
We founded and lead the global Medicines and Insurance Coverage (MedIC) Initiative; collaborate on the development of practical, valid methods to assess medicines situations; provide technical support in the design, development, and implementation of medicines policy and other intervention research studies in health systems; and support the dissemination of global medicines research.